[Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation].
D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000008:administration & dosage*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood; D009540:Nicotinyl Alcohol / Q000008:administration & dosage*; D010919:Placebos; D011725:Pyridines / Q000008:administration & dosage*; D014280:Triglycerides / Q000097:blood
D004338:Drug Combinations; D008074:Lipoproteins; D010919:Placebos; D011725:Pyridines; D014280:Triglycerides; D002784:Cholesterol; D009540:Nicotinyl Alcohol; D002994:Clofibrate
Klinische Prüfung einer Kombination von Clofibrat und beta-Pyridylcarbinol mit ungewöhnlicher Dosisrelation